http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101961021-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-866 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-39 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 |
| filingDate | 2017-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101961021-B1 |
| titleOfInvention | Hydrogel composition for transplanting pancreatic islet cells and pharmaceutical composition for treating diabetes comprising the same |
| abstract | The present invention relates to a hydrogel composition for pancreatic islet cell transplantation and a pharmaceutical composition for treating diabetes comprising the same. The hydrogel of the present invention is configured to further include not only pancreatic islet cells but also microspheres encapsulating tacrolimus and liposomal claudonate to inhibit acute immune response upon transplantation of pancreatic islet cells, When the hydrogel was subcutaneously injected, it was confirmed that blood glucose was maintained constant over a long period of time. Therefore, the present invention is expected to contribute to the treatment of diabetes by protecting pancreatic islet cells from in vivo immune response and improving the success rate of pancreatic islet cell transplantation. |
| priorityDate | 2017-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 312.